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Abstract
Background. Insomnia is considered an additional cardiovascular (CV) risk factor (RF). However, the data on its 
association with vascular damage is controversial. We analyzed the relation between self-reported insomnia and 
carotid atherosclerosis in the population-based sample.
Material and methods. We selected 985 (males — 38%; mean age 45.2 ± 11.6 years) participants of the St Peters-
burg population-based sample (the ESSE-RF study) who did not have previously known CV events. All subjects 
underwent a structured interview (lifestyle, medical history). Insomnia was diagnosed when complaints occurred 
≥ 3 times/week (the questions: “How often did you have difficulties in falling asleep for > 30 min after going to 
bed in the last month?”, “How often did you have difficulties in falling asleep after midnight awakening in the last 
month?”). Subclinical atherosclerosis was assessed by carotid intima-media thickness (IMT): normal ≤ 0.9 mm, 
increased IMT 0.9–13 mm, IMT > 13 mm indicated an atherosclerotic plaque. 
Results. In total, 209 subjects reported at least one insomnia complaint; 79 participants (8%) reported both sleep-
onset and sleep-maintenance problems. IMT thickening was found in 142 subjects (14.4%). IMT values were higher 
in those with frequent nocturnal awakenings vs. non-insomniacs (0.75 ± 0.18 vs. 0.71 ± 0.17 mm, p = 0.006). They 
also showed greater prevalence of thickened IMT (c2 = 4.6, p = 0.026). Mean IMT weakly correlated with insomnia 
complaints (r = 0.10, p = 0.002), but the association was no longer significant after adjustment for age, BP and 
total cholesterol level. 
Conclusion. We demonstrated an association between insomnia complaints and subclinical carotid atherosclerosis, 
although we assume it to be weak compared to the common CV RF.
Keywords: insomnia; carotid atherosclerosis; subclinical atherosclerosis; cardiovascular risk factors; cardiovascular 
prevention
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Introduction
Insomnia is defined as a subjective feeling of either 
inability to fall asleep or to maintain sleep or the 
dissatisfaction of sleep quality, or perception of un-
refreshed sleep despite the adequate opportunities 
to sleep [1, 2]. To make a diagnosis of insomnia the 
complaints should occur at least three times per week 
for at least three months and lead to a distress or im-
pairment in daily functioning. Insomnia is a highly 
prevalent sleep disorder which is reported by about 
30% in general population. Its prevalence is even 
higher in elderly subjects and specific patient cohorts 
(e.g. psychiatric population) [3].
Recent cross-sectional and prospective studies sug-
gest an association between insomnia and cardio-
vascular disease [4]. A meta-analysis pooling data 
from 13 prospective studies including over 100 000 
healthy subjects demonstrated a significantly in-
creased risk of fatal and non-fatal cardiovascular 
events among subjects who at baseline reported in-
somnia symptoms [4].
However, there is lack of evidence of the relation 
between insomnia and vascular atherosclerotic in-
volvement. There are only few studies assessing the 
presence of subclinical atherosclerosis in insomniacs, 
and their data are highly controversial [5–9]. 
Therefore, we aimed at the assessment of the re-
lation between self-reported insomnia and asymp-
tomatic atherosclerosis in a population-based cohort 
from a large-scale epidemiology study of cardiovas-
cular diseases in the Russian Federation
Material and methods
The recruitment and selection of the patients for the 
presented analysis was performed from a sample of 
the multicenter observational study “Epidemiology 
of the cardiovascular diseases in different regions of 
the Russian Federation” (ESSE-RF). The ESSE-RF 
study is a 2-stage study performed in 16 regions of 
the Russian Federation (Fig. 1). In the present analy-
sis we included data only from the cross-sectional 
arm performed in St Petersburg. Stratified random 
sample (n = 1600, 25–64 years old) was formed 
based on the Kish selection method. All participants 
signed informed consent. The protocol was approved 
by the local ethical committee.
For the present analysis we excluded patients who 
had previously known coronary artery disease, stroke 
and severe cognitive decline. Therefore, altogether 
the data of 985 subjects were included in the analysis 
(Fig. 2, Tab. I). 
The survey was accomplished between 1 No-
vember 2012 and 25 November 2014. All subjects 
underwent a structured interview which included 
12 modules and considered the demographics data, 
lifestyle, medical history, complaints, and therapy. 
Detailed data on the methods used in the ESSE-RF 
study are described elsewhere [10, 11].
The survey included several questions for the as-
sessment of sleep disorders:
1. How often did you have difficulties in falling 
asleep for ≥ 30 min. after going to bed during the 
last month? 
To assess the prevalence
of subclinical arterial damage
To evaluate the factors associated
with subclinical arterial damage
I stage
Cross-sectional
II stage
Prospective
1600 subjects
Comparison of different methods
for the evatuation of subclinical 
arterial damage
To evaluate the prevalence 
of early vascular aging 
and its risk factors
1600 subjects
Figure 1. Design of the study „Epidemiology of the cardiovascular diseases in different regions of the Russian Federation” (ESSE-RF study)
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2. How often did you have difficulties in falling 
asleep after midnight awakening during the last 
month? 
3. How often did you have difficulties in staying 
awake when required? 
4. How often did you take sleeping pills during the 
last month? 
The answer options were the following: 1 — never; 
2 — < 1 time per week; 3 — 1–2 times per week; 
4 — ≥ 3 times per week.
Self-reported sleep-disordered breathing were as-
sessed by the following questions “Do you snore?” 
and “Do you have sleep apnea?” with the answer 
options “Yes”, “No”, “Do not know”.
Insomnia was evaluated based on the reported 
sleep-onset problems or nocturnal awakenings which 
occurred more than 3 times per week during the last 
month [1, 2]. The daytime sleepiness was considered 
when reported more than 3 times per week. 
All subjects underwent physical examination 
which included blood pressure (BP) and heart rate 
(HR) assessment, anthropometric measurements, 
and blood tests.
BP was assessed in accordance with the guide-
lines on the management of arterial hypertension of 
the European Society of Cardiology and European 
Society of Hypertension [12–14]. An automatic 
tonometer “OMRON M3 Expert” (Japan) was used 
for the BP and HR assessment: two measurements 
with the 2-minute interval were performed on the 
right hand after 5 minutes of rest in supine posi-
1600 citizens of St. Petersburg (random sample)
25–64 years old
Informed consent
Coronary artery disease (n = 20); stroke (n = 27)
Incomplete sleep questionnaire (n = 7)
Incomplete ultrasound examination (n = 561)
985 subjects
Baseline
Excluded
Included
in analysis
Figure 2. Study sample included in the present analysis
Table I. Clinical and demographic characteristics of the cohort
Parameter Value
Sex, male/female, n (%) 374 (38%)/611 (62%)
Age [years] 45.2 ± 11.6
BMI [kg/m2] 27.1 ± 5.3
Waist circumference 
(male/female), [cm] 95.9 ± 13.2 / 86.4 ± 14.0
Hip circumference 
(male/female), [cm] 104.4 ± 9.2 / 103.6 ± 10.8
Obesity (BMI ≥ 30 kg/m2), n (%) 257 (26%)
Hypertension, n (%) 417 (42%)
SBP [mm Hg] 127.3 ± 19.6
DBP [mm Hg] 78.7 ± 11.9
Smoking, n (%) 496 (50%)
Total cholesterol [mmol/L] 5.4 ± 1.2
LDL-cholesterol [mmol/L] 3.5 ± 1.0
HDL-cholesterol [mmol/L] 1.4 ± 0.4
Triglycerides [mmol/L] 1.05 (0.2; 7.5)
Dyslipidemia, n (%) 429 (44%)
Glucose [mmol/L] 5.2 ± 0.9
Hyperglycemia, n (%) 94 (9.5%)
Creatinine [umol/L] 67.3 ± 11.8
eGFR [mL/min/1.73 m2] 104.0 ± 12.8
C-reactive protein [mg/L] 0.87 (0.04; 19.87)
BMI — body mass index; SBP — systolic blood pressure; DBP — diastolic blood pressure; LDL — low 
density lipoprotein; HDL — high density lipoprotein; eGFR — estimated glomerular filtration rate
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tion. Subjects were considered hypertensive in case 
of systolic BP (SBP) ≥140 mm Hg and/or diastolic 
BP (DBP) ≥ 90 mm Hg or if they received antihy-
pertensive therapy.
Anthropometric measurements included height, 
weight, waist and hip circumferences. Body mass 
index (BMI) was calculated by the Quetlet equa-
tion: Weight (kg)/height2 (m2). BMI ≥ 30 kg/m2 was 
considered obesity. 
Blood tests included fasting lipids, creatinine and 
glucose (Abbott Architect 8000, Roche-diagnostics, 
USA), C-reactive protein (Cobas Integra 400 plus, 
Switzerland; Roche-diagnostics). Dyslipidemia was 
diagnosed when total cholesterol was 5.0 mmol/L 
and higher and/or low-density lipoprotein was 
3.0 mmol/L and higher or if the subject took hypo-
lipidemic drugs. Hyperglycemia was diagnosed when 
fasting glucose exceeded 6.1 mmol/L, diabetes mel-
litus was diagnosed either from the previous medical 
history, or if the glucose level was over 7.0 mmol/L. 
Glomerular filtration rate was estimated by the 
CKD-EPI formula [15]. 
Carotid atherosclerosis was assessed by the trained 
and experienced specialist using ultrasound tech-
nique (MySono U6, Samsung, Korea) according to 
the same standard protocol and current guidelines. 
The measurements were performed on both sides 
at the distance of 1 cm from the bifurcation of the 
common carotid artery on posterior wall at three po-
sitions (anterior, medial, and posterior longitudinal). 
Mean intima-media thickness (IMT) was calculated 
as the mean value of the three measurements on both 
sides. Carotid arteries were considered normal when 
intima-media complex was ≤ 0.9 mm.
Atherosclerosis was diagnosed when there was 
a thickening of intima-media complex more than 
0.9 mm, and the focal thickening more than 1.3 mm 
indicated atherosclerotic plaque.
For statistical analysis we used parametric statis-
tics. Descriptive statistics included mean and stan-
dard deviation values for the normally distributed 
variables. The data are presented as mean ± SD. We 
applied frequency analysis (c2) to assess the contin-
gency between nominal and categorical variables. 
We used univariate logistic regression analysis to as-
sess the associations between carotid atherosclerosis 
(as a dichotomous variable) and other parameters. 
We applied multivariate logistic regression to evalu-
ate the effect of self-reported insomnia on carotid 
atherosclerosis (IMT as a dichotomous variable). In 
multivariable models, we adjusted for potential con-
founders including age, gender, BP, total cholesterol 
level, low-density lipoprotein (LDL) level, diagnosis 
of hypertension, diabetes mellitus and hyperlipid-
emia, BMI, smoking status. The results are presented 
as odds ratio (OR) and 95% confidence interval 
(95% CI). The two-sided p-value < 0.05 was ac-
cepted to define the validity of the statistical hypoth-
esis. The software SPSS 20.0 was used to perform 
statistical analysis. 
Results
Characteristics of the cohort
In our sample, men comprised 38% (Tab. I). The 
mean age of the subjects was 45.2 ± 11.6 years. On 
average the sample was characterized by moderate 
overweight. The mean BP values were within normal 
range, but 42% of the subjects reported known hy-
pertension, and non-controlled SBP (≥ 140 mm Hg) 
or/and DBP (≥ 90 mm Hg) was registered in 279 
(28%) subjects. Based on the blood tests, hypercho-
lesterolemia was found in 690 (70%) subjects. Each 
3rd participant had diabetes mellitus, and 94 (9.5%) 
subjects had fasting hyperglycemia.
Frequency of the self-reported insomnia 
symptoms in the cohort
Based on the survey, every 5th subject reported at 
least one insomnia complaint; however, both difficul-
ties in falling asleep and midnight awakenings were 
reported by the minority of the participants (Fig. 3). 
Sleep-onset problems are more frequent than sleep-
maintenance difficulties. Only a small number of the 
participants reported hypnotic use (less than 3%) 
and daytime sleepiness (less than 7%).
As expected, women were more prevalent in the 
insomnia group. Also subjects with self-reported 
insomnia appeared to be older. There were more 
smokers and hypertensive subjects among insom-
niacs compared to those without regular insomnia 
complaints. At the same time, the rates of hypercho-
lesterolemia, hyperglycemia, and obesity were com-
parable in two groups (Tab. II).
There was no association between having com-
plaints of sleep-onset or sleep-maintenance difficul-
ties and self-reported snoring (c2 = 0.07, p = 0.81) or 
sleep apnea (c2 = 1.07, p = 0.38).
Association between insomnia and carotid 
atherosclerosis
Only a minority of the participants (n = 17, 1.7%) 
showed atherosclerotic plaques. Nevertheless, athero-
sclerotic plaques were more frequent among insom-
niacs, compared to subjects without sleep complaints 
(Tab. III). Due to the small number of the subjects 
with plaques, we also analyzed cases of the increased 
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IMT without plaque formation. The rate of abnormal 
IMT thickening was also higher in insomniacs (Fig. 4).
Increased IMT was more prevalent among those 
with nocturnal awakenings, while the rate of sub-
clinical atherosclerosis was similar among subjects 
with and without sleep-onset problems (Fig. 5).
Similarly, IMT values were greater in those with 
frequent nocturnal awakenings compared to non-in-
somniacs (0.75 ± 0.18 vs. 0.71 ± 0.17 mm, p = 0.006), 
although average IMT was within reference range. 
Univariate regression analysis demonstrated 
a weak association between mean IMT and insomnia 
complaints (r = 0.10, p = 0.002), and the relation is 
more significant in subjects with nocturnal awaken-
ings than in participants with sleep-onset problems 
(Tab. IV). However, the association was no longer 
Sleep-onset
problem
n = 168
17.1%
n = 120
12.2%
n = 209
21.2%
n = 79
8.0%
n = 26
2.6%
n = 65
6.6%
n = 9
0.9%
Awakenings Any complaint Both complaints Daytime
sleepines
Sleeping 
pills
Sleep complaints
+ sleepiness
25%
20%
15%
10%
5%
0
Figure 3. The frequency of self-reported sleep-related complaints in the studied cohort
Table II. Cardiovascular risk factors in insomniacs vs. non-insomniacs
Parameter Insomniacs (n = 209) Non-insomniacs (n = 776) c2, p-level
Sex (m), n (%) 60 (29%) 642 (60%) c2 = 9.7; p = 0.002
Age (years) 48.6 ± 11.2 44.3 ± 11.6 p < 0.001
BMI [kg/m2] 27.1 ± 5.3 p = 0.46
BP [mm Hg] 128 ± 19 /78 ± 11 127 ± 20 /79 ± 12 p = 0.72/p = 0.73
Smoking, n (%) 75 (36%) 305 (39%) c2 = 8.2; p = 0.01
Obesity, n (%) 57 (27%) 200 (26%) c2 = 0.17; p = 0.72
Hypertension, n (%) 115 (55%) 302 (39%) c2 = 17.4; p < 0.001
Dyslipidemia, n (%) 147 (70%) 493 (64%) c2 = 3.04; p = 0.09
Hyperglycemia, n (%) 17 (8%) 77 (10%) c2 = 0.64; p = 0.43
BMI — body mass index; BP — blood pressure
Table III. The frequency of carotid atherosclerotic lesions in insomniacs vs. non-insomniacs
Parameter Insomniacs (n = 209) Non-insomniacs (n = 776) c2, p-level
Atherosclerotic plaques 7 (3.3%) 10 (1.3%) c2 = 4.12; p = 0.042
Increased intima-media thickness
(> 0.9 mm) 39 (18.7%) 103 (13.3%) c
2 = 3.87; p = 0.049
Total, n 209 776
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significant after adjustment for age, BP and total 
cholesterol level (Tab. V). The adjustment for the 
hypnotic use did not affect the results.
Discussion
In our study, in a large adult population cohort with-
out evident cardiovascular disease we have identified 
a weak univariate association between asymptomatic 
carotid atherosclerosis and self-reported insomnia. 
Intriguingly, the nocturnal awakenings show stronger 
relation to the IMT values than sleep-onset difficul-
ties. However, the role of the common established 
cardiovascular risk factors (age, BP, cholesterol level) 
appears to be more significant. 
Among few studies which assessed subclinical 
atherosclerosis in insomnia patients, Ramos-Sepul-
veda et al. (2010) also did not find an association 
between self-reported sleep complaints and carotid 
Sleep-onset
difculties: Yes
2c  = 0.81
p = 0.37
2c  = 4.61
p = 0.032
87%
13%
79%
21%
86%
14%
83%
17%
Sleep-onset
difculties: No
IMT > 0.9 mm IMT £ 0.9 mm
Awakenings: Yes Awakenings: No
100
80
60
40
20
0
Figure 4. The prevalence of carotid atherosclerosis and self-related insomnia complaints; IMT — intima–media thickness
Figure 5. Intima-media thickness (IMT) and insomnia complaints
Sleep-onset problem
IM
T
 [
m
m
]
Awakenings Any complaint Both complaints
1.5
1.0
0.5
0
Yes
p = 0.23 p = 0.006 p = 0.003 p = 0.67
Yes Yes YesNo No No No
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IMT among 1605 middle-aged/elderly (> 40 years 
old) subjects from the Northern Manhattan Study 
(NOMAS) cohort [9]. In menopausal women in-
somnia among other menopausal symptoms was 
shown to have no association either with carotid 
IMT or with coronary artery calcification [8]. 
Potential discrepancy between subjective (self-
reported) complaints and true sleep quality might be 
one of the reasons for the lack of association in our 
study [16]. We can assume that in some situations 
the role of insomnia can be greater, e.g. in case of 
insomnia associated with short sleep duration. Thus, 
a large population study (n = 3789) by Chen et al. 
(2017) demonstrated that subjects with short sleep 
duration (defined as less than 5 hours per night) 
have higher risk of having carotid plaques when ad-
justed for other risk factors (OR = 1.28, 95% CI: 
1.05–1.56, p < 0.001) even after stratification for age 
[17]. The participants over the age of 60 years who 
reported short sleep duration have the highest risk 
of carotid plaque (OR = 3.46, 95% CI: 2.34–5.12, 
p < 0.01). The study by Nakazaki et al. (2012) also 
demonstrated that IMT is greater in insomnia sub-
jects; it correlates with SBP, DBP, and total sleep 
time [5]. Nagai et al. (2013) also found a correlation 
between persistent insomnia and IMT, and carotid 
artery stiffness [6]. However, in the latter study only 
elderly (> 65 years, n = 86 and > 70 years, n = 201) 
subjects were included. In our cohort, only 22 sub-
jects reported short sleep duration (< 6 hours per 
night) and only six of them demonstrated increased 
IMT, so due to the small number of cases the further 
analysis was not performed in this subgroup. 
Increased sympathetic activity, higher activity of 
renin-angiotensin-aldosterone system and hypothal-
amo-pituitary axis, circadian disorders, impaired in-
sulin sensitivity and others are discussed as potential 
mechanisms of the association between insomnia and 
atherosclerosis. These mechanisms can exacerbate hy-
pertension [18], BP variability [6], dyslipidemia con-
tributing to the development and progression of ath-
erosclerosis. We suppose that these effects might be 
more evident in subjects with more frequent arousals 
and nocturnal awakenings and can explain our find-
ing of stronger relation to the IMT [19, 20].
On the other hand, the lack of association be-
tween insomnia and carotid atherosclerosis in our 
cohort can be also explained by the fact that ultra-
sound technique provides only a rough evaluation 
of arterial atherosclerotic involvement when arterial 
lesion is already advanced, while the negative effects 
of insomnia can act at the earlier stages. 
Table IV. Association between self-reported insomnia and carotid atherosclerosis: univariate regression analysis
Insomnia complaints IMT mean(R2, p-level) OR (95% CI)
Sleep complaints 
(either sleep-onset or sleep-maintenance)
R2 = 0.009
p = 0.003 0.04 (0.014–0.065)
Sleep complaints 
(both sleep-onset or sleep-maintenance difficulties) p = 0.70 0.01 (–0.30–0.05)
Sleep-onset difficulties p = 0.27 0.02 (–0.01–0.05)
Awakenings R
2 = 0.008
p = 0.006 0.05 (0.013–0.077)
Sleep complaints + daytime sleepiness R
2 = 0.007
p = 0.011 0.14 (0.032–0.254)
IMT — intima–media thickness; OR — odds ratio; CI — confidence interval
Table V. Association between self-reported insomnia and carotid atherosclerosis: multivariate regression analysis
Adjusted for age
OR (95% CI), p-level
Adjusted for age, SBP
OR (95% CI), p-level
Adjusted for age, SBP, 
LDL-cholesterol
OR (95% CI), p-level
Sleep complaints (either sleep-onset 
or sleep-maintenance)
p = 0.14
0.006 (0.005–0.007)
p = 0.12
0.08 (–0.02–0.18)
p = 0.13
0.08 (–0.02–0.18)
Awakenings p = 0.520.01 (–0.02–0.04)
p = 0.45
0.01 (–0.02–0.04)
p = 0.47
0.01 (–0.02–0.04)
Sleep complaints 
+ daytime sleepiness
p = 0.14
0.08 (–0.03–0.18)
p = 0.09
0.0001 (0.0001–0.001)
p = 0.13
0.004 (–0.006–0.014)
OR — odds ratio; CI — confidence interval; SBP — systolic blood pressure; LDL — low density lipoprotein
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Carotid atherosclerosis, in particular, atheroscle-
rotic plaques in carotid arteries, is a well-known car-
diovascular risk factor, and according to the recently 
published 2018 ESC/ESH guidelines for the man-
agement of arterial hypertension, carotid plaques 
are considered a significant modifier of the cardio-
vascular risk [13]. On the other hand, the European 
Guidelines on cardiovascular prevention 2016 do 
not recommend the routine use of imaging tech-
niques for the assessment of increased IMT for risk 
stratification [21]. At the same time, the guidelines 
mention, that low predictive value on population 
level might be related to the lack of standardization 
in IMT assessment, its high variability and low re-
producibility [21]. However, there is a correlation 
between carotid atherosclerosis and atherosclerotic 
involvement of other arterial territories, and carotid 
atherosclerosis remains one of the common tools for 
the evaluation of arterial disease [22]. Therefore, the 
use of ultrasound carotid atherosclerosis is reason-
able for the assessment of atherosclerosis. In our 
study, ultrasound study was performed according to 
the same protocol in all subjects which minimizes 
the potential variability and bias. 
Study limitations
We recognize that our study has certain limitations. 
First, our analysis was based on a cross-sectional 
study, which does not allow making conclusions 
about causal effects between insomnia and subclinical 
atherosclerosis. Another important limitation is the 
lack of objective sleep evaluation which could help to 
verify and differentiate sleep disorders, as well as to 
exclude potential discrepancy between subjective and 
objective sleep parameters [16]. However, insomnia 
is a diagnosis based on the subjective symptoms [1, 
2], and objective methods play only an additional 
role. We also miss the results about early awaken-
ings due to the limited number of questions in the 
epidemiological survey. There is a gender imbalance 
in our insomniacs and non-insomniacs group with 
the significantly prevalent female population among 
those reporting insomnia symptoms. However, it 
corresponds to other studies data which showed that 
women are more likely to have lower sleep quality 
and shorter sleep [7, 23]. 
Conclusion
In general population, insomniacs demonstrate high-
er rate of subclinical carotid atherosclerosis includ-
ing the frequency of carotid atherosclerotic plaques. 
Self-reported nocturnal awakenings are stronger as-
sociated with the subclinical carotid atherosclerosis 
compared to the sleep-onset difficulties. In conclu-
sion, our study confirmed an association between 
insomnia complaints and subclinical carotid athero-
sclerosis, although this relation appears to be weak 
compared to the established cardiovascular risk fac-
tors, however, deserves further investigation.
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